Lucid Psycheceuticals
Lucid Psycheceuticals is a Canada-based biotechnology firm that researches and develops novel therapeutics for depression, anxiety, dementia and neurodegenerative diseases.
Business Model:
Revenue: $2M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Lucid Psycheceuticals Information
Lucid Psycheceuticals was acquired by
FSD Pharma.
The acquisition happend on 2021-08-25.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 1 Adelaide Street East
City: Toronto
State: ontario
Zip: M5C 2V9
Country: CA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Lucid Psycheceuticals is a Canada-based biotechnology firm that researches and develops novel therapeutics for depression, anxiety, dementia and neurodegenerative diseases.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
